Trial Profile
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Therapeutic Use
- Sponsors Revance Therapeutics
- 27 Dec 2013 According to ClinicalTrials.gov record trial status changed from active, no longer recruiting to completed.
- 04 Nov 2013 New trial record